Why is it relevant?

Cardiac Surgery

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

Why is it relevant?
Prof. Robert F Storey, Sheffield/UK

Why is it relevant?

February 2, 2021
Cardiac Surgery

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

Why is it relevant?
Prof. Robert F Storey, Sheffield/UK

BACK TO MEDIACENTER

More Videos

Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021

How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021

Jak można ograniczyć powikłania krwotoczne i koszty? | Stephan Geidel | With Polish Voice Over

Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021

Why is it relevant? | Robert F Storey | Webinar 1 | 2021